• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES GORE HELEX SEPTAL OCCLUDER; OCCLUDER, TRANSCATHETER SEPTAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES GORE HELEX SEPTAL OCCLUDER; OCCLUDER, TRANSCATHETER SEPTAL Back to Search Results
Catalog Number HX1530
Device Problem Appropriate Term/Code Not Available (3191)
Patient Problems Thrombus (2101); Therapeutic Response, Decreased (2271)
Event Date 02/24/2014
Event Type  Injury  
Event Description
A patient reported having a gore helex septal occluder implanted on (b)(6) 2010 to close a patent foramen ovale.A follow-up visit on (b)(6) 2010 noted a thrombus on a disc.The patient was prescribed blood thinners.3d transesophageal echocardiography was performed at a follow-up on (b)(6) 2010, and no thrombus was noted.At a follow-up on (b)(6) 2014, imaging showed movement in the right atrial disc and a residual shunt.The left atrial disc appeared well apposed with good tissue ingrowth.Imaging performed in (b)(6) 2014 noted shunting and the right disc was not well apposed, but the device appeared stable.No additional follow-up was recommended.
 
Manufacturer Narrative
A review of the manufacturing records verified the lot was processed normally and all pre-release specifications were met.Images have been received for analysis and the investigation is ongoing.
 
Manufacturer Narrative
Imaging evaluation summary: initial implant procedure ((b)(6) 2010) intracardiac echocardiography images showed normal cardiac structures with a chiari network branching off of the eustachian ridge in the right atrium.A patent foramen ovale was assessed and a small shunt was observed.A 30mm gore® helex septal occluder was implanted with good results.On (b)(6) 2010 the patient had transthoracic echocardiography performed.Imaging revealed good disc apposition throughout the anterior superior sections of the aorta.The right disc was slightly flared near the end of the aortic root, possibly conforming to the septal anatomy.Flow was observed between the right disc and the septum, but color doppler did not reveal shunting through the discs.In the superior vena cava view, a section of the right disc was extending into the right atrium.A thread-like structure was observed extending toward the inferior section of the right disc, possibly pulling on the disc and causing it to flare.The superior edge of the left disc was slightly lifted.Bubble studies were performed at rest and valsalva.At rest, no bubbles were observed in the left atrium.When valsalva was performed, a few bubbles were observed in the left atrium.Additional echocardiography was performed on (b)(6) 2010, (b)(6) 2011.During these follow-up examinations no changes to the device appearance were observed, no shunt was detected with color flow, no bubbles were detected at rest, and a few bubbles were noted when valsalva was performed.On (b)(6) 2014 echocardiography was performed.Imaging revealed the gore® helex septal occluder remained in the same position with little to no observable changes in the appearance of the discs.The superior edge of the left disc remained lifted with suboptimal apposition.The right disc remained flared at the aortic level and at the superior vena cava level, where the disc was extending into the right atrium.The right disc appeared stable and did not appear to be mobile.A bubble study at rest remained negative.A bubble study with valsalva performed showed additional bubbles in the left atrium as compared to the previous examination.The right disc extending into the right atrium may be attributed to septal anatomy, such as chiari tissue interference with the device, or a possible frame fracture.Fluoroscopy images were not provided; therefore, a frame fracture cannot be confirmed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE HELEX SEPTAL OCCLUDER
Type of Device
OCCLUDER, TRANSCATHETER SEPTAL
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
Manufacturer (Section G)
KENDRICK PEAK MPD B/P
4250 w. kiltie lane
flagstaff AZ 86001
Manufacturer Contact
marci stewart
1500 n. 4th street
flagstaff, AZ 86004
9285263030
MDR Report Key3776695
MDR Text Key4437689
Report Number2017233-2014-00221
Device Sequence Number1
Product Code MLV
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P050006
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Company Representative
Reporter Occupation Patient
Type of Report Initial,Followup
Report Date 05/13/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/28/2014
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date02/29/2012
Device Catalogue NumberHX1530
Device Lot Number7614159
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured03/22/2010
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age31 YR
Patient Weight66
-
-